Beyond the LabelSign in
theskindex
Tuesday, October 13, 2026Index last updated Oct 9
The Index  ·  Synthetic prostaglandin analogue

Ethyl Tafluprostamide

Ethyl Tafluprostamide

Prostaglandin analogue used in some lash and brow formulas; US Panel has a revised draft tentative report while EU SCCS already judged related PGAs unsafe for lash/brow growth claims.

EmergingCIR conclusion TBD; related EU SCCS PGA opinion was not safe for lash/brow growth use.
Sign in to save and follow
Written byTheSkindex Desk
Reviewed byNot yet reviewed
Last updated18 Sept 2026
Sources2 cited

Ethyl Tafluprostamide is a synthetic prostaglandin analogue listed as a hair- and nail-conditioning agent. It is under joint CIR review with isopropyl Cloprostenate.[1]

What it does

Prostaglandin analogues are used in some eyelash and eyebrow growth cosmetics because related drug-class molecules can lengthen the hair cycle. That pharmacology is exactly why regulators scrutinise ocular side effects (intraocular pressure, iris colour change, periorbital fat loss).[1][2]

The evidence

CIR released a revised Draft Tentative Report on 11 September 2026 after earlier insufficient-data announcements and a 2024 table to wait for industry studies.[1] Separately, the EU Scientific Committee on Consumer Safety concluded in February 2026 that three prostaglandin analogues assessed for lash and brow growth — including isopropyl cloprostenate — could not be considered safe for that use, citing potent pharmacology and inadequate data to exclude adverse effects.[2] Ethyl tafluprostamide itself was not one of the three SCCS-named molecules, but it sits in the same analogue class CIR is weighing.

How to use it

If a lash serum lists this INCI, treat it as a pharmacologically active analogue, not a bland conditioner. Prefer products and markets that disclose concentration and ocular-risk labelling; watch the October CIR meeting for a US Panel conclusion.

Evidence by claim

Graded separately; the entry grade is the best-supported claim
Used in some eyelash/eyebrow conditioning formulas as a prostaglandin analogue[1][2]
Function from Dictionary; safety conclusion pending CIR and informed by SCCS class concerns.
Emerging

Safety & limits

Source and region, always
eyelash and eyebrow products — CIR Draft Tentative Report (Sep 2026) — conclusion to be determined.[1] US
eyelash and eyebrow growth products — SCCS/1680/25 found three assessed PGAs (including isopropyl cloprostenate) not safe for lash/brow growth cosmetics; ethyl tafluprostamide was outside that specific trio.[2] EU

Sources · 2

Numbered as cited in the text
  1. [1]Revised Draft Tentative Report: Safety Assessment of Ethyl Tafluprostamide and Isopropyl Cloprostenate as Used in Cosmetics. Cosmetic Ingredient Review (2026)
  2. [2]SCCS / European Commission. Opinion on prostaglandin analogues used in cosmetic products (SCCS/1680/25). SCCS (2026)

Revision history

18 Sept 2026Drafted by botTheSkindex Desk